• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

系统性红斑狼疮患者无菌性坏死出现相关影响因素的计算机分析

Computer analysis of factors influencing the appearance of aseptic necrosis in patients with SLE.

作者信息

Dimant J, Ginzler E M, Diamond H S, Schlesinger M, Marino C T, Weiner M, Kaplan D

出版信息

J Rheumatol. 1978 Summer;5(2):136-41.

PMID:671430
Abstract

A computer analysis of 234 patients with SLE followed for an average of 31 months revealed 22 patients with aseptic necrosis of bone (AN) (9%), with projected frequency approaching 30% at 10-15 years of follow-up. Most patients developed between four and seven years after diagnosis of SLE. When compared to all other patients with SLE and no AN or to three computer-selected groups matched by age of SLE diagnosis, duration of disease, or cumulative corticosteroid dose, AN did not correlate with any of the preliminary ARA criteria, total number of criteria fulfilled, renal disease, skin vasculitis, or disease activity. Although all patients received corticosteroid therapy prior to development of AN, no correlation was found with duration, peak dose, or cumulative dose of corticosteroid therapy.

摘要

对234例系统性红斑狼疮(SLE)患者进行平均31个月的随访,计算机分析显示22例患者发生骨无菌性坏死(AN)(9%),预计随访10 - 15年时发生率接近30%。大多数患者在SLE诊断后4至7年发病。与所有其他无AN的SLE患者或与按SLE诊断年龄、病程或累积皮质类固醇剂量计算机选择匹配的三组患者相比,AN与任何初步的美国风湿病学会(ARA)标准、符合标准的总数、肾脏疾病、皮肤血管炎或疾病活动度均无相关性。虽然所有患者在发生AN之前均接受了皮质类固醇治疗,但未发现与皮质类固醇治疗的持续时间、峰值剂量或累积剂量相关。

相似文献

1
Computer analysis of factors influencing the appearance of aseptic necrosis in patients with SLE.系统性红斑狼疮患者无菌性坏死出现相关影响因素的计算机分析
J Rheumatol. 1978 Summer;5(2):136-41.
2
Aseptic necrosis of bone in systemic lupus erythematosus. Relationship to corticosteroid therapy.
Arch Intern Med. 1978 May;138(5):750-4.
3
Aseptic necrosis and glucocorticosteroids in systemic lupus erythematosus: a reevaluation.系统性红斑狼疮中的无菌性坏死与糖皮质激素:重新评估
J Rheumatol. 1989 May;16(5):604-8.
4
Disease activity as a major risk factor for osteonecrosis in early systemic lupus erythematosus.疾病活动是早期系统性红斑狼疮患者发生骨坏死的主要危险因素。
Lupus. 2007;16(4):239-44. doi: 10.1177/0961203307076771.
5
Predictive factors for symptomatic osteonecrosis in patients with systemic lupus erythematosus.系统性红斑狼疮患者症状性骨坏死的预测因素
J Rheumatol. 2001 Apr;28(4):761-5.
6
Four years follow-up of bone mineral density change in premenopausal women with systemic lupus erythematosus.绝经前系统性红斑狼疮女性骨密度变化的四年随访
J Med Assoc Thai. 2004 Nov;87(11):1374-9.
7
[Renal graft survival in patients with systemic lupus erythematosus].[系统性红斑狼疮患者的肾移植存活率]
Rev Invest Clin. 2002 Jan-Feb;54(1):21-8.
8
Tuberculosis in systemic lupus erythematosus in an endemic area and the role of isoniazid prophylaxis during corticosteroid therapy.流行地区系统性红斑狼疮患者的结核病及皮质类固醇治疗期间异烟肼预防的作用
J Rheumatol. 2005 Apr;32(4):609-15.
9
Spontaneous repair of asymptomatic osteonecrosis associated with corticosteroid therapy in systemic lupus erythematosus: 10-year minimum follow-up with MRI.系统性红斑狼疮患者接受皮质类固醇治疗后无症状性骨坏死的自发修复:10 年 MRI 随访结果。
Lupus. 2010 Oct;19(11):1307-14. doi: 10.1177/0961203310372951. Epub 2010 Jul 6.
10
[Osteonecrosis in systemic lupus erythematosus. Report of 3 cases].[系统性红斑狼疮中的骨坏死。3例报告]
An Med Interna. 1997 Jun;14(6):307-9.

引用本文的文献

1
Glucocorticoid-induced osteonecrosis in systemic lupus erythematosus patients.系统性红斑狼疮患者的糖皮质激素诱导性骨坏死。
Clin Transl Med. 2021 Oct;11(10):e526. doi: 10.1002/ctm2.526.
2
[Atypical arthritis of the hands : Collagenosis-part 1].[手部非典型关节炎:胶原病 - 第1部分]
Radiologe. 2021 May;61(5):458-469. doi: 10.1007/s00117-021-00840-4. Epub 2021 Mar 29.
3
Risk factors for symptomatic Avascular Necrosis (AVN) in a multi-ethnic Systemic Lupus Erythematosus (SLE) cohort.多民族红斑狼疮(SLE)队列中症状性缺血性坏死(AVN)的危险因素。
PLoS One. 2021 Mar 19;16(3):e0248845. doi: 10.1371/journal.pone.0248845. eCollection 2021.
4
Avascular necrosis of the femoral head due to low-dose corticosteroid used in a patient with panhypopituitarism: A case report and literature review.全垂体功能减退患者使用低剂量皮质类固醇导致的股骨头缺血性坏死:一例报告及文献综述
Jt Dis Relat Surg. 2020;31(2):390-394. doi: 10.5606/ehc.2020.72773. Epub 2020 Jun 18.
5
Osteonecrosis of the Hip: A Primer.髋关节骨坏死:入门指南。
Perm J. 2019;23. doi: 10.7812/TPP/18-100.
6
Bilateral femoral head avascular necrosis with a very low dose of oral corticosteroid used for panhypopituitarism.双侧股骨头缺血性坏死,使用极低剂量口服糖皮质激素治疗全垂体功能减退症。
BMJ Case Rep. 2016 Jan 13;2016:bcr2015212803. doi: 10.1136/bcr-2015-212803.
7
High-Dose Corticosteroid Use and Risk of Hip Osteonecrosis: Meta-Analysis and Systematic Literature Review.大剂量使用皮质类固醇与髋部骨坏死风险:荟萃分析与系统文献综述
J Arthroplasty. 2015 Sep;30(9):1506-1512.e5. doi: 10.1016/j.arth.2015.03.036. Epub 2015 Apr 8.
8
Risk factors for avascular bone necrosis in patients with systemic lupus erythematosus.系统性红斑狼疮患者发生缺血性骨坏死的危险因素。
Rheumatol Int. 2012 Jan;32(1):177-82. doi: 10.1007/s00296-010-1597-9. Epub 2010 Aug 15.
9
Steroid induced osteonecrosis: An analysis of steroid dosing risk.类固醇诱导性骨坏死:类固醇剂量风险分析。
Autoimmun Rev. 2010 Sep;9(11):721-43. doi: 10.1016/j.autrev.2010.06.007. Epub 2010 Jul 9.
10
Osteonecrosis secondary to antiphospholipid syndrome: a case report, review of the literature, and treatment strategy.抗磷脂抗体综合征继发骨坏死:病例报告、文献复习及治疗策略。
Rheumatol Int. 2010 Apr;30(6):719-23. doi: 10.1007/s00296-009-1269-9. Epub 2009 Dec 12.